A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

Recruiting

Phase 2

LY4005130A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

Sponsor:

Eli Lilly and Company

Code:

NCT07533006

Conditions

Alopecia Areata

Eligibility Criteria

Sex: All

Age: 18 - 50

Healthy Volunteers: Not accepted

Interventions

LY4005130

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-14. This information was provided to ClinicalTrials.gov by Eli Lilly and Company on 2026-04-27.